Cargando…
Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2
Numerous biomolecular interactions involve unstructured protein regions, but how to exploit such interactions to enhance the affinity of a lead molecule in the context of rational drug design remains uncertain. Here clarification was sought for cases where interactions of different ligands with the...
Autores principales: | Bueren-Calabuig, Juan A., Michel, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457491/ https://www.ncbi.nlm.nih.gov/pubmed/26046940 http://dx.doi.org/10.1371/journal.pcbi.1004282 |
Ejemplares similares
-
Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2
por: Houston, Douglas R., et al.
Publicado: (2015) -
Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms
por: Pollock, Raphael E., et al.
Publicado: (1997) -
Regulation of the Abundance of Kaposi’s Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2
por: Chang, Tzu-Hsuan, et al.
Publicado: (2016) -
Discovery of a novel ligand that modulates the protein–protein interactions of the AAA+ superfamily oncoprotein reptin
por: Healy, Alan R., et al.
Publicado: (2015) -
A Quantitative Systems Approach to Define Novel Effects of Tumour p53 Mutations on Binding Oncoprotein MDM2
por: Fuentes, Manuel, et al.
Publicado: (2021)